2. Classification and Diagnosis of Diabetes:<i>Standards of Care in Diabetes—2023</i>Nuha A. ElSayed, Robert A. Gabbay, Grazia Aleppo et al.|Diabetes Care|2022Cited by 2.4k
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J. Davies, John B. Buse, Vanita R. Aroda et al.|Diabetes Care|2022Cited by 1.9k
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J. Davies, John B. Buse, Vanita R. Aroda et al.|Diabetologia|2022Cited by 986
9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Care in Diabetes—2023</i>Nuha A. ElSayed, Robert A. Gabbay, Kamlesh Khunti et al.|Diabetes Care|2022Cited by 850
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trialRichard E. Pratley, Adie Viljoen, Vanita R. Aroda et al.|The Lancet Diabetes & Endocrinology|2018Cited by 758